These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
576 related articles for article (PubMed ID: 29559558)
1. The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling. Baran P; Hansen S; Waetzig GH; Akbarzadeh M; Lamertz L; Huber HJ; Ahmadian MR; Moll JM; Scheller J J Biol Chem; 2018 May; 293(18):6762-6775. PubMed ID: 29559558 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor. Garbers C; Thaiss W; Jones GW; Waetzig GH; Lorenzen I; Guilhot F; Lissilaa R; Ferlin WG; Grötzinger J; Jones SA; Rose-John S; Scheller J J Biol Chem; 2011 Dec; 286(50):42959-70. PubMed ID: 21990364 [TBL] [Abstract][Full Text] [Related]
3. Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling. Hashizume M; Mihara M Rheumatol Int; 2009 Feb; 29(4):397-401. PubMed ID: 18802703 [TBL] [Abstract][Full Text] [Related]
4. Different Soluble Forms of the Interleukin-6 Family Signal Transducer gp130 Fine-tune the Blockade of Interleukin-6 Trans-signaling. Wolf J; Waetzig GH; Chalaris A; Reinheimer TM; Wege H; Rose-John S; Garbers C J Biol Chem; 2016 Jul; 291(31):16186-96. PubMed ID: 27226573 [TBL] [Abstract][Full Text] [Related]
5. The IL-6-neutralizing sIL-6R-sgp130 buffer system is disturbed in patients with type 2 diabetes. Aparicio-Siegmund S; Garbers Y; Flynn CM; Waetzig GH; Gouni-Berthold I; Krone W; Berthold HK; Laudes M; Rose-John S; Garbers C Am J Physiol Endocrinol Metab; 2019 Aug; 317(2):E411-E420. PubMed ID: 31237452 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 and its receptors: a highly regulated and dynamic system. Wolf J; Rose-John S; Garbers C Cytokine; 2014 Nov; 70(1):11-20. PubMed ID: 24986424 [TBL] [Abstract][Full Text] [Related]
8. IL-6 trans-signaling system in intra-amniotic inflammation, preterm birth, and preterm premature rupture of the membranes. Lee SY; Buhimschi IA; Dulay AT; Ali UA; Zhao G; Abdel-Razeq SS; Bahtiyar MO; Thung SF; Funai EF; Buhimschi CS J Immunol; 2011 Mar; 186(5):3226-36. PubMed ID: 21282511 [TBL] [Abstract][Full Text] [Related]
9. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses. Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125 [TBL] [Abstract][Full Text] [Related]
10. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Jostock T; Müllberg J; Ozbek S; Atreya R; Blinn G; Voltz N; Fischer M; Neurath MF; Rose-John S Eur J Biochem; 2001 Jan; 268(1):160-7. PubMed ID: 11121117 [TBL] [Abstract][Full Text] [Related]
11. Alternative intronic polyadenylation generates the interleukin-6 trans-signaling inhibitor sgp130-E10. Sommer J; Garbers C; Wolf J; Trad A; Moll JM; Sack M; Fischer R; Grötzinger J; Waetzig GH; Floss DM; Scheller J J Biol Chem; 2014 Aug; 289(32):22140-50. PubMed ID: 24973212 [TBL] [Abstract][Full Text] [Related]
12. Increased levels of IL-6, sIL-6R, and sgp130 in the aqueous humor and serum of patients with diabetic retinopathy. Chen H; Zhang X; Liao N; Wen F Mol Vis; 2016; 22():1005-14. PubMed ID: 27563232 [TBL] [Abstract][Full Text] [Related]
13. Identification of IL-6 Signalling Components as Predictors of Severity and Outcome in COVID-19. Rodríguez-Hernández MÁ; Carneros D; Núñez-Núñez M; Coca R; Baena R; López-Ruiz GM; Cano-Serrano ME; Martínez-Tellería A; Fuentes-López A; Praena-Fernandez JM; Garbers C; Hernández-Quero J; García F; Rose-John S; Bustos M Front Immunol; 2022; 13():891456. PubMed ID: 35634332 [TBL] [Abstract][Full Text] [Related]
14. Soluble gp130 is up-regulated in the implantation window and shows altered secretion in patients with primary unexplained infertility. Sherwin JR; Smith SK; Wilson A; Sharkey AM J Clin Endocrinol Metab; 2002 Aug; 87(8):3953-60. PubMed ID: 12161539 [TBL] [Abstract][Full Text] [Related]
15. The Soluble Interleukin 6 Receptor: Advanced Therapeutic Options in Inflammation. Rose-John S Clin Pharmacol Ther; 2017 Oct; 102(4):591-598. PubMed ID: 28675418 [TBL] [Abstract][Full Text] [Related]
16. Circulating interleukin 6 and soluble forms of its receptors in relation to resting energy expenditure in women with anorexia nervosa. Karczewska-Kupczewska M; Adamska A; Nikołajuk A; Otziomek E; Górska M; Kowalska I; Strączkowski M Clin Endocrinol (Oxf); 2013 Dec; 79(6):812-6. PubMed ID: 23199226 [TBL] [Abstract][Full Text] [Related]
17. The classic signalling and trans-signalling of interleukin-6 are both injurious in podocyte under high glucose exposure. Lei CT; Su H; Ye C; Tang H; Gao P; Wan C; He FF; Wang YM; Zhang C J Cell Mol Med; 2018 Jan; 22(1):251-260. PubMed ID: 28881473 [TBL] [Abstract][Full Text] [Related]
19. Measurements of IL-6, soluble IL-6 receptor and soluble gp130 in sera of B-cell lymphoma patients. Does viscum album treatment affect these parameters? Kovacs E; Kuehn JJ Biomed Pharmacother; 2002 May; 56(3):152-8. PubMed ID: 12046687 [TBL] [Abstract][Full Text] [Related]
20. Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma-associated herpesvirus. Aoki Y; Narazaki M; Kishimoto T; Tosato G Blood; 2001 Nov; 98(10):3042-9. PubMed ID: 11698289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]